{"entity":{"type":"insider","cik":"0001592279","url":"/insider/0001592279","json_url":"/insider/0001592279.json","name":"Edwardson Peter","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2016-11-16","last":"2017-08-24","span_basis":"filed_date"},"name_variants":[{"name":"Edwardson Peter","source":"filing","n_filings":6,"first_seen":"2016-11-16","last_seen":"2017-08-24"}],"transactions":[{"id":9288074,"accession":"0001437749-17-015254","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-015254","line_url":"/filing/0001437749-17-015254#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9739.0,"shares_display":"9,739","price_per_share":16.1383,"price_display":"16.14","price_state":"stated","total_value":157170.9037,"total_display":"157,170.90","total_whole":"157,171","shares_owned_after":92905.0,"shares_owned_after_display":"92,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-24","scope":"insider"},{"id":5333520,"accession":"0001437749-17-014904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-014904","line_url":"/filing/0001437749-17-014904#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9739.0,"shares_display":"9,739","price_per_share":16.1383,"price_display":"16.14","price_state":"stated","total_value":157170.9037,"total_display":"157,170.90","total_whole":"157,171","shares_owned_after":92905.0,"shares_owned_after_display":"92,905","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-15","filed_date":"2017-08-16","scope":"insider"},{"id":4554411,"accession":"0001437749-17-014288","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-014288","line_url":"/filing/0001437749-17-014288#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":22371.0,"shares_display":"22,371","price_per_share":17.7002,"price_display":"17.70","price_state":"stated","total_value":395971.1742,"total_display":"395,971.17","total_whole":"395,971","shares_owned_after":102644.0,"shares_owned_after_display":"102,644","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-08-07","filed_date":"2017-08-09","scope":"insider"},{"id":4879880,"accession":"0001437749-17-009399","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-17-009399","line_url":"/filing/0001437749-17-009399#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":14.6572,"price_display":"14.66","price_state":"stated","total_value":146572.0,"total_display":"146,572.00","total_whole":"146,572","shares_owned_after":125015.0,"shares_owned_after_display":"125,015","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-15","filed_date":"2017-05-16","scope":"insider"},{"id":5089051,"accession":"0001437749-17-003889","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-17-003889","line_url":"/filing/0001437749-17-003889#line-2","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5923.0,"shares_display":"5,923","price_per_share":14.9219,"price_display":"14.92","price_state":"stated","total_value":88382.4137,"total_display":"88,382.41","total_whole":"88,382","shares_owned_after":48271.0,"shares_owned_after_display":"48,271","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-03-03","filed_date":"2017-03-06","scope":"insider"},{"id":2530203,"accession":"0001437749-16-042266","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-16-042266","line_url":"/filing/0001437749-16-042266#line-1","is_derivative":false,"issuer_cik":"0001586049","issuer_name":"Oxford Immunotec Global PLC","issuer_ticker":"OXFD","issuer_name_source":null,"issuer_url":"/issuer/0001586049","owner_cik":"0001592279","owner_name":"Edwardson Peter","owner_display_name":"Edwardson Peter","owner_url":"/insider/0001592279","role":"Officer (Chief Operations Officer)","role_mark":"O","role_mark_label":"Officer (Chief Operations Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Operations Officer","security_title":"Ordinary Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4869.0,"shares_display":"4,869","price_per_share":14.0922,"price_display":"14.09","price_state":"stated","total_value":68614.9218,"total_display":"68,614.92","total_whole":"68,615","shares_owned_after":48932.0,"shares_owned_after_display":"48,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-08","filed_date":"2016-11-16","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001586049","name":"Oxford Immunotec Global PLC","url":"/issuer/0001586049","role":"Officer (Chief Operations Officer)","n_filings":6,"first_seen":"2016-11-16","last_seen":"2017-08-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001592279","retrieved_at":"2026-08-25T08:09:35+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}